Beijing Scitop Bio-tech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Operating Revenue	372.85	365.46	302.37	298.87	368.24	364.09
Other Revenue	0.46	0.46	0.43	0.37	0.93	0.52
Revenue	373.31	365.92	302.79	299.24	369.17	364.62
Revenue Growth (YoY)	16.16%	20.85%	1.19%	-18.94%	1.25%	7.51%
Cost of Revenue	185.57	177.72	126.41	135.91	177.29	181.17
Gross Profit	187.73	188.2	176.38	163.33	191.88	183.45
Selling, General & Admin	72.77	71.32	67.9	58.03	56.86	63.26
Research & Development	36.58	35.71	36.33	34.19	22.09	27.15
Other Operating Expenses	7.35	5.57	5.27	4.92	3.76	3.06
Operating Expenses	124.72	115.64	106.35	98.94	83.43	93.81
Operating Income	63.01	72.56	70.03	64.39	108.45	89.64
Interest Expense	-0.06	-0.14	-0.25	-0.5	-0.41	-0.44
Interest & Investment Income	21.76	22.05	28.34	30.13	12.82	18.35
Other Non Operating Income (Expenses)	-0.04	-0.01	-0.03	-0.05	-0.05	-0.04
EBT Excluding Unusual Items	84.67	94.45	98.08	93.97	120.81	107.52
Gain (Loss) on Sale of Investments	2.03	1.62	2.01	1.26	0.17	1.55
Gain (Loss) on Sale of Assets	-	-	0.65	0.03	-0.01	11.2
Asset Writedown	-0.02	-0.02	-0.31	-0	-0	-0.15
Other Unusual Items	8.81	7.78	8.39	6.78	4.69	4.06
Pretax Income	95.5	103.83	108.83	102.04	125.66	124.17
Income Tax Expense	6.36	9.31	14.47	8.56	15.76	14.63
Earnings From Continuing Operations	89.14	94.52	94.36	93.48	109.89	109.54
Net Income	89.14	94.52	94.36	93.48	109.89	109.54
Net Income to Common	89.14	94.52	94.36	93.48	109.89	109.54
Net Income Growth	-7.31%	0.17%	0.94%	-14.93%	0.32%	13.42%
Shares Outstanding (Basic)	261	263	262	267	224	222
Shares Outstanding (Diluted)	261	263	262	267	224	222
Shares Change (YoY)	0.70%	0.17%	-1.87%	19.09%	1.00%	16.50%
EPS (Basic)	0.34	0.36	0.36	0.35	0.49	0.49
EPS (Diluted)	0.34	0.36	0.36	0.35	0.49	0.49
EPS Growth	-7.95%	-	2.86%	-28.57%	-0.67%	-2.65%
Free Cash Flow	-103.05	-172.68	-69.38	-71.21	64.28	42.7
Free Cash Flow Per Share	-0.39	-0.66	-0.27	-0.27	0.29	0.19
Dividend Per Share	0.100	0.100	0.150	0.150	0.200	0.333
Dividend Growth	-33.33%	-33.33%	-	-25.00%	-39.99%	-10.02%
Gross Margin	50.29%	51.43%	58.25%	54.58%	51.98%	50.31%
Operating Margin	16.88%	19.83%	23.13%	21.52%	29.38%	24.59%
Profit Margin	23.88%	25.83%	31.16%	31.24%	29.77%	30.04%
Free Cash Flow Margin	-27.61%	-47.19%	-22.91%	-23.80%	17.41%	11.71%
EBITDA	97.6	105.21	94.91	82.87	125.09	104.55
EBITDA Margin	26.15%	28.75%	31.35%	27.69%	33.88%	28.68%
D&A For EBITDA	34.6	32.65	24.88	18.48	16.64	14.91
EBIT	63.01	72.56	70.03	64.39	108.45	89.64
EBIT Margin	16.88%	19.83%	23.13%	21.52%	29.38%	24.59%
Effective Tax Rate	6.66%	8.97%	13.30%	8.39%	12.55%	11.79%
Revenue as Reported	373.31	365.92	302.79	299.24	369.17	364.62
Advertising Expenses	-	19.85	18.08	19.22	7.92	9.94